Acromegaly Trials in Warsaw, Poland
Conditions / Acromegaly / Warsaw, Poland
Research into Acromegaly spans multiple therapeutic approaches and trial phases.
18 total trials for this combination
Showing top 10 of 18 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01794793 | Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies | COMPLETED | PHASE4 |
| NCT02060383 | Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly | COMPLETED | PHASE4 |
| NCT03548415 | Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands | COMPLETED | PHASE2 |
| NCT00600886 | Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly | COMPLETED | PHASE3 |
| NCT02396953 | Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly | COMPLETED | PHASE1/PHASE2 |
| NCT04522180 | A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly | COMPLETED | PHASE2 |
| NCT03252353 | Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly | UNKNOWN | PHASE3 |
| NCT07037420 | ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly | RECRUITING | PHASE2 |
| NCT01412424 | Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly | COMPLETED | PHASE3 |
| NCT00765323 | Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly | TERMINATED | PHASE3 |